1-5 of 5
Lin Wu, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

EPCR Guides Hematopoietic Stem Cells Homing to the Bone Marrow Independently of Niche Clearance

Shiri Gur-Cohen, PhD, Francesca Avemaria, PhD, Orit Kollet, PhD, Seymen Avci, MSc, Tomer Itkin, PhD, Saravana K. Ramasamy, PhD, Anjali P. Kusumbe, PhD, Karin Golan, PhD, Eman Khatib-Massalha, Msc, Anju Kumari, PhD, Mayela M. Carolina, PhD, Wei-Ling Lin, PhD, Qing-Cissy Yu, PhD, Hua-Lin Wu, PhD, Yi Arial Zeng, PhD, Ralf H. Adams, PhD, Conway M. Edward, PhD, Elizabeth J. Shpall, MD, Ayelet Erez, PhD, Irit Sagi, PhD, Charles T. Esmon, PhD, Wolfram Ruf, MD, Tsvee Lapidot, PhD
Journal: Blood
Blood (2016) 128 (22): 4538.
https://doi.org/10.1182/blood.V128.22.4538.4538
Published: 2016
Journal Articles

Mutational Analysis of TP53 Gene in Chronic Lymphocytic Leukemia: Comparison of Different Methodological Approaches

Barbara Kantorova, MSc., Jitka Malcikova, Dr., PhD., Jana Kminkova, PharmD., Veronika Navrkalova, MSc., Barbora Dvorakova, MSc., Boris Tichy, Dr., PhD., Jana Smardova, Prof., Martin Trbusek, Dr., PhD., Sim Truong, PhD., Katerina Stano-Kozubik, PhD., Nikola Tom, MSc., Karol Pal, MSc., Ludmila Sebejova, Dr., Nancy Patten, PhD., Lin Wu, PhD., Michael Doubek, M.D., PhD., Prof., Jiri Mayer, M.D., PhD., Prof., Sarka Pospisilova, Dr., PhD., Prof.
Journal: Blood
Blood (2012) 120 (21): 3911.
https://doi.org/10.1182/blood.V120.21.3911.3911
Published: 2012
Journal Articles

Pharmacodynamic Biomarkers in the Phase 1 Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

Michael Andreeff, MD, PhD, Kensuke Kojima, MD, PhD, Vivian Ruvolo, Anas Younes, MD, Wei Wei, Marina Konopleva, MD, PhD, Seshagiri Duvvuri, Xuelin Huang, PhD, Lin Wu, PhD, Lori Jukofsky, Lyubomir Vassilev, PhD, Jianguo Zhi, PhD, David Geho, MD, Gwen Nichols, MD
Journal: Blood
Blood (2011) 118 (21): 1545.
https://doi.org/10.1182/blood.V118.21.1545.1545
Published: 2011
Journal Articles

Clinical Impact of TP53 Gene Mutations in Diffuse Large B-Cell Lymphoma (DLBCL): An International DLBCL Rituxan-CHOP Consortium Program Study.

Ken H. Young, MD, PhD, Nancy Patten, PhD, Sim Truong, PhD, Jens Eickhoff, PhD, Gabrielle L. Rocque, MD, Jeffrey T. Malik, MD, Yan Li, PhD, Kazunori Kanehira, MD, PhD, Matthew Twohig, MD, William M. Rehrauer, PhD, Michelle A. Waknitz, MS, Brad S. Kahl, MD, Michael B. Moller, MD, PhD, Alexander Tzankov, PhD, Santiago M. Moreno, MD, Miguel A. Piris, MD, Carlo Visco, MD, Karen Dybkaer, PhD, April Chiu, MD, Attilio Orazi, MD, Jeff C. Chang, MD, PhD, Govind Bhagat, MD, Jane N. Winter, MD, Huan-You Wang, MD, PhD, Cherie Dunphy, MD, Stacey O'Neill, MD, PhD, Eric D. Hsi, MD, Xianfeng Zhao, MD, PhD, Kristin Hunt, MD, Weina Chen, MD, PhD, Ronald S. Go, MD, William W.L. Choi, MD, Fan Zhou, MD, PhD, Magdalena Czader, MD, PhD, Yong Li, PhD, Suzanne Selvaggi, MD, James S. Malter, MD, Lin Wu, PhD
Journal: Blood
Blood (2009) 114 (22): 967.
https://doi.org/10.1182/blood.V114.22.967.967
Published: 2009
Journal Articles

Screening for TP53 Mutations Identifies Chronic Lymphocytic Leukemia Patients with Rapid Disease Progression.

Frank Dicker, PhD, Hannes Herholz, Susanne Schnittger, PhD, Aki Nakao, Nancy Patten, Lin Wu, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD
Journal: Blood
Blood (2007) 110 (11): 490.
https://doi.org/10.1182/blood.V110.11.490.490
Published: 2007